High molecular weight amyloid β1‐42 oligomers induce neurotoxicity via plasma membrane damage
暂无分享,去创建一个
H. Nishijo | D. Teplow | Y. Takamura | H. Inoue | S. Yano | Tomio Inoue | K. Ono | Y. Kiuchi | Mayumi Tsuji | Taro Yasumoto | Shiro Nakamura | K. Imamura | T. Watanabe-Nakayama | Atsushi Michael Kimura
[1] Christian Peters,et al. Effect of Cholesterol on Membrane Fluidity and Association of Aβ Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword , 2018, Front. Aging Neurosci..
[2] T. Kálai,et al. A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta , 2018, Molecules.
[3] P. Palumaa,et al. In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells , 2017, PloS one.
[4] M. Tomás,et al. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease , 2017, Redox biology.
[5] K. Ono. Alzheimer's disease as oligomeropathy , 2017, Neurochemistry International.
[6] Z. Leonenko,et al. Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease , 2017, PloS one.
[7] Z. Khachaturian,et al. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.
[8] J. H. Viles,et al. Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes* , 2016, The Journal of Biological Chemistry.
[9] K. Kawakami,et al. Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons , 2016, Scientific Reports.
[10] M. Gairí,et al. Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments , 2016, Proceedings of the National Academy of Sciences.
[11] C. Dobson,et al. Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells , 2016, Scientific Reports.
[12] Kenjiro Ono,et al. High-speed atomic force microscopy reveals structural dynamics of amyloid Β1-42 aggregates , 2016, Journal of the Neurological Sciences.
[13] J. Hardy,et al. The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.
[14] C. Masters,et al. Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons* , 2015, The Journal of Biological Chemistry.
[15] A. Bogaerts,et al. Effect of lipid peroxidation on membrane permeability of cancer and normal cells subjected to oxidative stress , 2015, Chemical science.
[16] James C. Lee,et al. Role of membrane biophysics in Alzheimer's–related cell pathways , 2015, Front. Neurosci..
[17] R. Nussinov,et al. Role of the Fast Kinetics of Pyroglutamate-Modified Amyloid-β Oligomers in Membrane Binding and Membrane Permeability , 2014, Biochemistry.
[18] A. Milelli,et al. Oxidative stress in Alzheimer's disease: are we connecting the dots? , 2014, Journal of medicinal chemistry.
[19] J. Renger,et al. A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid , 2014, The Journal of Neuroscience.
[20] Shinya Yamanaka,et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells , 2014, Scientific Reports.
[21] M. Pohanka. Alzheimer´s disease and oxidative stress: a review. , 2013, Current medicinal chemistry.
[22] B. Hyman,et al. Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] S. Maiti,et al. Thermodynamically stable amyloid-β monomers have much lower membrane affinity than the small oligomers , 2013, Front. Physiol..
[24] R. Nussinov,et al. Mechanisms for the Insertion of Toxic, Fibril-like β-Amyloid Oligomers into the Membrane. , 2013, Journal of chemical theory and computation.
[25] Florentina Tofoleanu,et al. Molecular interactions of Alzheimer's Aβ protofilaments with lipid membranes. , 2012, Journal of molecular biology.
[26] W. Markesbery,et al. Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression , 2012, Neurobiology of Aging.
[27] Toshio Ando,et al. Guide to video recording of structure dynamics and dynamic processes of proteins by high-speed atomic force microscopy , 2012, Nature Protocols.
[28] Hans-Ulrich Demuth,et al. Prion-Like Behavior and Tau-dependent Cytotoxicity of Pyroglutamylated β-Amyloid , 2012, Nature.
[29] H. Nishijo,et al. Phenolic compounds prevent beta-amyloid-protein oligomerization and synaptic dysfunction by site-specific binding , 2012, Alzheimer's & Dementia.
[30] H. Qing,et al. Calcium channel blockers and Alzheimer's disease , 2012, Neural regeneration research.
[31] I. Parker,et al. Single-channel Ca2+ imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology , 2011, The Journal of cell biology.
[32] Thomas L. Williams,et al. Membrane and surface interactions of Alzheimer’s Aβ peptide – insights into the mechanism of cytotoxicity , 2011, The FEBS journal.
[33] D. Cribbs,et al. Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1 , 2011, Alzheimer's & Dementia.
[34] K. Matsuzaki,et al. Mechanism of amyloid β-protein aggregation mediated by GM1 ganglioside clusters. , 2011, Biochemistry.
[35] E. Klann,et al. Reactive oxygen species in the regulation of synaptic plasticity and memory. , 2011, Antioxidants & redox signaling.
[36] D. Teplow,et al. Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid β-Protein Assembly and Toxicity* , 2010, The Journal of Biological Chemistry.
[37] I. Bezprozvanny,et al. The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.
[38] S. Scheff,et al. Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex , 2010, Journal of neuropathology and experimental neurology.
[39] P. Faller,et al. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease. , 2009, Biochimie.
[40] D. Teplow,et al. Structure-neurotoxicity relationships of amyloid β-protein oligomers , 2009, Neuroscience Research.
[41] M. Berridge. Calcium signalling in health and disease. , 2009, Biochemical and biophysical research communications.
[42] Weiming Xia,et al. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. , 2009, Archives of neurology.
[43] D. Walsh,et al. Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases , 2008, Molecular medicine.
[44] Grace E. Stutzmann. The Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”? , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[45] M. Sakakibara,et al. Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats , 2007, Neurobiology of Aging.
[46] Roberto Cappai,et al. The redox chemistry of the Alzheimer's disease amyloid β peptide , 2007 .
[47] W. Gattaz,et al. Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus , 2005, Journal of Neural Transmission.
[48] Ian Parker,et al. Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.
[49] Roger Anwyl,et al. Synaptic plasticity in animal models of early Alzheimer's disease. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[50] M. Kirkitadze,et al. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[51] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[52] C. Yip,et al. Aβ42-Peptide Assembly on Lipid Bilayers , 2002 .
[53] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[54] D. Butterfield,et al. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.
[55] T. Ando,et al. A high-speed atomic force microscope for studying biological macromolecules , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[56] S. Younkin,et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.
[57] And J. Sklansky,et al. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. , 2000, Biochemistry.
[58] E. Niki,et al. A novel fluorescent probe diphenyl‐1‐pyrenylphosphine to follow lipid peroxidation in cell membranes , 2000 .
[59] Y. Shai,et al. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.
[60] Dominic M. Walsh,et al. Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.
[61] D. Selkoe,et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.
[62] D. Walsh,et al. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.
[63] C. Finch,et al. Evidence for Apoptotic Cell Death in Alzheimer's Disease , 1995, Experimental Neurology.
[64] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[65] K. Ono,et al. High-Speed Atomic Force Microscopy of Individual Amyloidogenic Protein Assemblies. , 2018, Methods in molecular biology.
[66] Brian J. Wiltgen,et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-b , 2012 .
[67] I. Parker,et al. Single-channel Ca 2+ imaging implicates A 1–42 amyloid pores in Alzheimer’s disease pathology , 2011 .
[68] N. Arispe. Architecture of the Alzheimer’s AβP Ion Channel Pore , 2003, The Journal of Membrane Biology.
[69] C. Yip,et al. Abeta42-peptide assembly on lipid bilayers. , 2002, Journal of molecular biology.
[70] M. Kirkitadze,et al. Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. , 2002 .
[71] N. Noguchia,et al. A novel fluorescent probe diphenyl-1-pyrenylphosphine to follow lipid peroxidation in cell membranes. , 2000, FEBS letters.